Omnivision AG
SwitzerlandFDA applicant, unverified
- Devices
- 1
What Omnivision AG makes
Omnivision AG manufactures MaxiTears Contacts PF, a device designed for ocular surface hydration and tear retention in patients with dry eye syndrome.
The device portfolio is regulated under Class II classification in the US and is listed via FDA 510(k) clearance. The company is based in the United States.
Catalogue
MaxiTears Contacts PF Ref K182984
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Omnivision AG have in the registry?
The registry currently lists 1 device for Omnivision AG. Devices recorded under merged duplicate company entries are counted once.
Which registries list Omnivision AG's devices?
Among its 1 most recently registered device, Omnivision AG has devices listed in FDA 510(k) (1 device).
What risk classes do Omnivision AG's devices fall under?
Among its 1 most recently registered device, the classes recorded for Omnivision AG's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Omnivision AG in the registry?
The most recently registered devices listed for Omnivision AG include MaxiTears Contacts PF.